Proguanil

Proguanil

SCHEMBL45726

CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 1/20 0.41
CNR1 P21554 2/20 0.40
EPHX1 P07099 1/20 0.40
CYP1A2 P05177 1/20 0.40
ADRA2A P08913 1/20 0.40
CYP2D6 P10635 1/20 0.40
DRD1 P21728 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KCNH2 Q12809 1/20 0.40
TSHR P16473 1/20 0.40
NPC1 O15118 2/20 0.39
HTT P42858 2/20 0.39
RAB9A P51151 2/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proguanil SCHEMBL2543837 0.98 LMNA (0.40) LMNAMEN1KMT2AALDH1A1CNR1
Proguanil SCHEMBL218859 0.98 LMNA (0.40) LMNAMEN1KMT2AALDH1A1CNR1
Proguanil SCHEMBL9247094 0.94 MEN1 (0.40) LMNAMEN1KMT2AALDH1A1CNR1
Proguanil SCHEMBL2539379 0.92 MEN1 (0.46) LMNAMEN1KMT2AALDH1A1CNR1
SCHEMBL1989233 0.91 ALDH1A1 (0.44) LMNAMEN1KMT2AALDH1A1CNR1
Proguanil SCHEMBL2545386 0.90 ALDH1A1 (0.43) LMNAMEN1KMT2AALDH1A1CNR1
SCHEMBL2350583 0.85 ALDH1A1 (0.49) LMNAMEN1KMT2AALDH1A1CNR1
SCHEMBL11236184 0.85 NPC1 (0.50) LMNAMEN1KMT2AALDH1A1CNR1
SCHEMBL24080891 0.84 MAPT (0.47) LMNAMEN1KMT2AALDH1A1CYP1A2
Hydrochloric Acid SCHEMBL13584911 0.83 NPC1 (0.48) LMNAMEN1KMT2AALDH1A1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8833 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144251-A1 ANTIMICROBIAL NANOCLAYS COMPRISING CATIONIC ANTIMICROBIALS, METHOD OF PREPARATION AND USES THEREOF POLYAMYNA NANOTECH INC. (CA) 2026-05-28 US claimed
EP-4499765-B1 COMPOSITIONS AND METHODS FOR TUNGSTEN ETCHING INHIBITION BASF SE (DE) 2026-05-06 EP claimed
EP-4255391-B1 LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION METRIOPHARM AG (CH) 2026-05-06 EP claimed
EP-4722714-A1 SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) Korea Institute of Science and Technology (KR) 2026-04-08 EP claimed
EP-4680248-A1 PRODUCTS OF MANUFACTURE AND THERAPEUTIC COMPOSITIONS FOR TREATING, AMELIORATING OR PREVENTING VIRAL INFECTIONS AND METHODS FOR MAKING AND USING THEM Topelia Aust Limited (ACN 652 771 670) (AU) 2026-01-21 EP claimed
US-12529704-B2 Methods for objective assessment of stress, early detection of risk for stress disorders, matching individuals with treatments, monitoring response to treatment, and new methods of use for drugs INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2026-01-20 US claimed
US-12509439-B2 Anti-malarial agents UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2025-12-30 US claimed
US-20250388603-A1 ANTIMALARIAL COMPOUNDS SCRIPPS RESEARCH INST (US) 2025-12-25 US claimed
WO-2025244856-A1 METHODS AND COMPOSITIONS RELATING TO ELQ COMPOUNDS OREGON HEALTH & SCIENCE UNIVERSITY (US) 2025-11-27 WO claimed
EP-3625238-B1 NOVEL SPIRO-LACTAM COMPOUNDS, PROCESS AND USES THEREOF UNIV DE COIMBRA (PT) 2025-11-26 EP claimed
EP-0504290-A4 INHIBITORS OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE 1993-03-24 EP claimed
EP-0504290-A1 INHIBITORS OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE. PROTOS CORP (US) 1992-09-23 EP claimed
EP-0422097-A4 METHOD OF INHIBITING THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN VIVO 1992-03-11 EP claimed
US-5084449-A Bactericides and antiprotozoa agents DR. KARL THOMAE GMBH (DE) 1992-01-28 US claimed
WO-1991008667-A1 INHIBITORS OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE PROTOS CORPORATION (US) 1991-06-27 WO claimed
WO-1991008668-A1 INHIBITORS OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE PROTOS CORPORATION (US) 1991-06-27 WO claimed
EP-0422097-A1 METHOD OF INHIBITING THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN VIVO. DAVIS MICHAEL H (US) 1991-04-17 EP claimed
EP-0361894-A2 Loading and controlled release of amphiphatic molecules to and from liposomes YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 1990-04-04 EP claimed
WO-1990000055-A1 METHOD OF INHIBITING THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN VIVO DAVIS MICHAEL H (US) 1990-01-11 WO claimed
EP-0152379-A2 Process for preparing pharmaceutical compositions containing unilamellar liposomes CIBA-GEIGY AG (CH) 1985-08-21 EP claimed